Clinical characteristics, comorbidities and mortality in critically ill mechanically ventilated patients with Covid-19: a retrospective observational study
Aim To analyse demographic data, clinical symptoms and signs, laboratory data and comorbidities in patients with COVID-19 pneumonia admitted to the intensive care unit (ICU), mechanically ventilated with fatal outcome. Methods Medical records of 92 patients were retrospectively analysed. Demographic data, clinical symptoms and comorbidities were collected on the day of hospital admission. Clinical signs and laboratory data were collected on the day of hospital admission (T1), on the day of starting non-invasive ventilation (T2), and on the day of starting invasive ventilation (T3). Results Average age of the patients was 60.05 years. Patients over 50 years of age, 71 (77.1%) (p=0.000), and males, 62 (67.4%; p=0.001) were predominant. The most common patient symptoms were exhaustion, myalgia, dyspnoea and cough. Hyperthermia was recorded on the day of hospital admission. Tachycardia, hyperglycaemia, hypoxemia were recorded at all observed study times. The most common comorbidity was hypertension arterialis with a very strong correlation with fatal outcome, followed by diabetes mellitus and chronic heart disease that were moderately correlated with fatal outcome. Conclusion The treatment of COVID-19 patients in ICU with mechanical ventilation has a high failure rate. Demographic data, clinical symptoms and signs as well as accompanying comorbidities can be a significant component in making decisions about diagnostic-therapeutic procedures.
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its impact on patients with CO-VID-19. SN Compr Clin Med 2020:1–8.
2
Auld S, Caridi-Scheible M, Blum J, Robichaux C, Kraft C, Jacob J, et al. Emory COVID-19 Quality and Clinical Research Collaborative. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med 2020:e804.
3
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 2020:497–506.
4
Baj J, Karakuła-Juchnowicz H, Teresinski G, Buszewicz G, Ciesielka M, Sitarz E, et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J Clin Med 2020:1753.
5
Conci S, Ruzzenente A, Donadello K, Cybulski A, Pedrazzani C, Campagnaro T, et al. Haemodynamic instability in a critically ill patient with covid-19 pneumonia: searching over the chest -report of a clinical case and mini-review of the literature. Case Rep Imag Surg 2020:1–3.
6
Bhandari S, Rankawat G, Singh A. Impact of glycemic control in diabetes mellitus on management of COVID-19 infection. Int J Diabetes Dev Ctries 2020:340–5.
7
Singh A, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract 2020:108382.
8
Batah S, Fabro A. Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians. Respir Med 2021:106239.
9
Franks T, Chong P, Chui P, Galvin P, Lourens J, Reid R, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 2003:743–8.
10
Van Halem K, Bruyndonck R, Van Der Hilst J, Cox J, Driesen P, Opsomer M, et al. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study. BMC Infect Dis 2020:897.
11
Harrisonsl F, Eynullayeva E, Lane D, Underhill P, Lip G. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med 2020:1003321.
12
Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: a metaanalysis. Nutr Metab Cardiovasc Dis n.d.:745–55.
13
Seiglie J, Platt J, Cromer S, Bunda B, Foulkes A, Bassett I, et al. Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes Care 2020:2938–44.
14
Leung J, Niikura M, Yang C, Sin D. COVID-19 and COPD. Eur Respir J 2020.
15
Guan W-J, Liang W-H, Shi Y, Gan L-X, Wang H-B, He J-X, et al. Chronic respiratory diseases and the outcomes of COVID-19: a nationwide retrospective cohort study of 39,420 cases. J Allergy Clin Immunol Pract 2021.
16
Phelps M, Christensen M, Gerds T, Fosbøl E, Torp-Pedersen C, Schou M, et al. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Heart J Qual Care Clin Outcomes 2021:172–80.
17
Kummer B, Klang E, Stein L, Dhamoon M, Jetté N. History of stroke is independently associated with in-hospital death in patients with COVID-19. Stroke 2020:3112–4.
18
Lu H, Stratton C, Tang Y. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol 2020:401–2.
19
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020:1574–81.
20
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020:1708–20.
21
Chawla R, Nasa P. Ventilatory management of CO-VID-19-related ARDS: stick to basics and infection control. Indian J Crit Care Med 2020:609–10.
22
Sa N-S. Respiratory support for patients with COVID-19 infection. Lancet Respir Med 2020:18.
23
Zádori N, Váncsa S, Farkas N, Hegyi P, Eross BKS, Group. The negative impact of comorbidities on the disease course of COVID-19. Intensive Care Med 2020:1784–6.
24
Macedo A, Gonã §alves N, Febra C. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemol 2021:14–21.
25
Lepper P, Muellenbach R. Mechanical ventilation in early COVID-19 ARDS. EClinicalMedicine 2020:100616.
26
Grasselli G, Cattaneo E, Florio G, Ippolito M, Zanella A, Cortegiani A, et al. Mechanical ventilation parameters in critically ill CO-VID-19 patients: a scoping review. Crit Care 2021:115.
27
Gibson P, Qin L, Puah S. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust 2020:54–6.
28
Santus P, Radovanovic D, Saderi L, Marino P, Cogliati C, Filippis D, et al. Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study. BMJ Open 2020:43651.
29
Mcaloon C, Collins Á, Hunt K, Barber A, Byrne A, Butler F, et al. The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research. BMJ Open 2020:39652.
30
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneu-monia in Wuhan, China: a descriptive study. Lancet 2020:507–13.
31
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan. Lancet Respir Med 2020:475–81.
32
Baloch S, Baloch A, Zheng M, T, Pei. The coronavirus disease 2019 (COVID-19) pandemic. Tohoku. J Exp Med 2020:271–8.
33
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. JAMA 2020:1061–9.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
